SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
14557564
Source:
http://linkedlifedata.com/resource/pubmed/id/14557564
Search
Subject
(
63
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0002771
,
umls-concept:C0006050
,
umls-concept:C0034656
,
umls-concept:C0599724
,
umls-concept:C1280500
pubmed:issue
7
pubmed:dateCreated
2003-10-14
pubmed:abstractText
Botulinum toxin type A (BTXA) is used to treat neurologic disorders associated with increased muscle tone. Its use is often associated with pain relief.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0401060
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Analgesics
,
http://linkedlifedata.com/resource/pubmed/chemical/Botulinum Toxins, Type A
,
http://linkedlifedata.com/resource/pubmed/chemical/Capsaicin
,
http://linkedlifedata.com/resource/pubmed/chemical/Placebos
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1526-632X
pubmed:author
pubmed-author:AuffEE
,
pubmed-author:EichlerH GHG
,
pubmed-author:GustorffBB
,
pubmed-author:LehrSS
,
pubmed-author:SchmettererLL
,
pubmed-author:SchniderPP
,
pubmed-author:SychaTT
,
pubmed-author:VollerBB
pubmed:issnType
Electronic
pubmed:day
14
pubmed:volume
61
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
940-4
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:14557564-Adult
,
pubmed-meshheading:14557564-Analgesics
,
pubmed-meshheading:14557564-Botulinum Toxins, Type A
,
pubmed-meshheading:14557564-Capsaicin
,
pubmed-meshheading:14557564-Double-Blind Method
,
pubmed-meshheading:14557564-Electric Stimulation
,
pubmed-meshheading:14557564-Female
,
pubmed-meshheading:14557564-Forearm
,
pubmed-meshheading:14557564-Hot Temperature
,
pubmed-meshheading:14557564-Humans
,
pubmed-meshheading:14557564-Hyperalgesia
,
pubmed-meshheading:14557564-Injections, Intradermal
,
pubmed-meshheading:14557564-Male
,
pubmed-meshheading:14557564-Nerve Fibers, Myelinated
,
pubmed-meshheading:14557564-Nerve Fibers, Unmyelinated
,
pubmed-meshheading:14557564-Pain
,
pubmed-meshheading:14557564-Pain Measurement
,
pubmed-meshheading:14557564-Pain Threshold
,
pubmed-meshheading:14557564-Placebos
,
pubmed-meshheading:14557564-Reference Values
,
pubmed-meshheading:14557564-Skin
,
pubmed-meshheading:14557564-Treatment Outcome
pubmed:year
2003
pubmed:articleTitle
A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A.
pubmed:affiliation
Department of Clinical Pharmacology, University of Vienna, Austria. vollerb@ninds.nih.gov
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't